Connect with us

Headlines

Bausch + Lomb Investment Sparks Good News for Valeant

mm

Published

on

New owner has invested $128 million in reorganization.

The $8.7 billion that Valeant Pharmaceuticals spent to purchase Bausch + Lomb Inc. last fall is apparently paying off. Even factoring in the $128 million the Montreal-based pharmaceuticals giant invested in a major overhaul of the B + L operation, Valeant reported record earnings for the quarter following the acquisition — $125 million, versus the previous year’s fourth quarter net loss of $89 million. Valeant’s sales for the fourth quarter of 2013 were $2.06 billion, more than double the $986 million it took in the same three months in 2012. Since Valeant’s takeover of the iconic eye care company, it has cut more than 400 positions at its manufacturing facilities in Rochester NY, and moved administrative headquarters from Rochester to New Jersey.

Read more at Rochester Democrat and Chronicle

SPONSORED VIDEO

SPONSORED BY VARILUX

The Best Overall Progressive Lens, Now Powered by AI

Engineered with Behavioral Artificial Intelligence and utilizing new XR-motion™ technology, Varilux XR series goes beyond prescription and eye physiology to consider the patient’s visual behavior and design a progressive lens that respects how
their eyes naturally move.

Varilux XR series comes in two versions, Varilux® XR design and Varilux® XR track. The Varilux XR track lens provides an additional level of personalization by incorporating the exclusive Near Vision Behavior Measurement, providing up to 25% more near vision width3 according to the patient’s need, so patients get the highest level of customization.

Discover Varilux XR series and enjoy instantly sharp vision in motion4 and seamless transitions from near to far.

For more information, visit here.

Promoted Headlines

Advertisement

Advertisement

Subscribe

INVISIONMAG.COM
BULLETINS

Get the most important news and business ideas for eyecare professionals every weekday from INVISION.

Advertisement

Advertisement

Most Popular